InflaRx appoints Gabriela Alperovich as SVP, global head of clinical development

Bitget2026/10/01 11:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

InflaRx appointed Gabriela Alperovich as senior vice president and global head of clinical development, effective Oct. 1, 2026.
Alperovich most recently served at CSL Vifor as executive director and global clinical lead for cardiovascular and renal programs.
Her prior roles include clinical development or medical affairs leadership at CSL Vifor, AbbVie, and Bristol-Myers Squibb.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inflarx NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610010730PRIMZONEFULLFEED9837813) on October 01, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

InflaRx appoints Gabriela Alperovich as SVP, global head of clinical development

You may also like

Crypto prices